The assignment with chromosome banding techniques of the breakpoints of the recurrent translocation t(3;5) which leads to NPM1/MLF1 gene fusion in myeloid malignancies has not been unequivocal. In order to assess whether this is due to uncertainty in interpretation of the observed banding pattern or whether it reflects true genomic heterogeneity, we decided to analyze the breakpoint positions using fluorescence in situ (FISH) techniques in eight patients with myeloid malignancies and rearrangements of chromosomes 3 and 5. In three patients, colocalization of the NPM1 and MLF1 spanning BACs was demonstrated and NPM1/MLF1 fusion shown by PCR in one while in the remaining cases breakpoints were located outside the NPM1 and MLF1 loci. Interestingly, loss of a copy of the NPM1 gene was found in three of these latter patients. This findings suggest that haploinsufficiency of NPM1 may play a role in subtypes of myelodysplasias and leukemias.
Introduction
Following the first reports in 1976 by Rowley and Potter 1 and by Oshimura et al. 2 in patients with acute myeloblastic leukemia (AML), translocation t(3;5) was recognized as a nonrandom and uncommon abnormality ocurring in AML and myelodysplastic syndromes (MDS). The location of the chromosomal breakpoints by banding techniques, however, has been variable in the cases reported in the literature, 3 although the description as t(3;5)(q25.1;q34) was the most probable according to Raimondi et al. 4 The variability of the breakpoint location may be due to a true diversity and the difficulty to precisely localize the rearranged bands on chromosomes 3 and 5 long arms by conventional cytogenetics. Since the description of the NMP1-MLF1 fusion resulting from t(3;5), 5 fluorescence in situ hybridization (FISH) techniques with appropriate DNA probes allow for rapid assessment for the presence of this rearrangement in t(3;5) positive myeloid proliferations. The results of analysis of eight examples of t(3;5) collected in the Groupe Francophone de Cytogénétique Hématologique (GFCH) are reported here.
Materials and methods
Clinical-hematological and conventional cytogenetic data of eight patients with t(3;5) are summarized in Table 1 . Banding techniques were applied and results of karyotype studies reviewed by the cytogeneticists of the GFCH. Besides painting, commercial specific probes and multi-FISH were used in patients 5 and 7, whereas NPM1 (RP1-1021H23 and BAC 891F8) and MLF1 (RP11-163I16) specific BAC probes were systematically used in seven of the eight cases. The latter assay was performed as dual color assay and should yield two fusion signals, one on each respective derivative chromosome. The probes used are listed in Table 2 . FISH was performed according to the usual techniques 6 and the recommendations of the manufacturers. RT-PCR was performed in case 4 according to Pallisgaard et al. 
Results
FISH or RT-PCR analysis of eight patients with hematopoietic disorder and t(3;5) or rearrangement of chromosomes 3 and 5 was performed to compare the results of conventional cytogenetics and FISH with probes detecting the NPM1/MLF1 gene fusion.
Patients 1-4: Fusion of the two genes was detected in three patients by FISH showing splitting of the NPM1 and MLF1 BAC probes, whereas in one patient (no. 4) the fusion transcript was detected by RT-PCR. The localization of the breakpoints by conventional cytogenetics was clearly in accordance with FISH analysis in patients 1-3, but discordant with the result of RT-PCR in patient 4.
The chromosomal rearrangements of the four other patients, two of which showed complex karyotypes, did not show NPM1/ MLF1 fusion and were less easy to define, even by FISH analysis (Table 3) .
Patient 5: FISH analysis confirmed that the der(5) resulted from t(3;5)(q21;31) but showed evidence for deletion on chromosome 5 as evidenced by the absence of signals for the probes covering the EGR1, CSFR1, and NPM1 loci. BACs RP11-117J8 (covering EPH1B in 3q22.2), BAC RP11-722C17 5 (covering RPN1 in 3q23.3), BAC RP11-163I16 (covering MLF1), and BAC RP11 211G3 (covering BCL6 in 3q27) showed hybridization signals on der(5) chromosomes. This result indicates that the breakpoint on the der(5) was located proximal to the EGR1 locus on 5q31 and that the der(5) resulted from an unbalanced translocation with the distal part of a chromosome 3, with a breakpoint located between the EPH1B and MLF1 loci, respectively, in 3q22 and 3q25.
Patient 6: FISH analysis with the MLF1 probe showed that the der(5) resulting from t(3;5) exhibited a hybridization signal on its distal part. As in patient 5, loss of signal with the NPM1 probe was noted indicating the translocation was unbalanced. The breakpoints were thus proximal to the NPM1 locus (5q35) on chromosome 5 and proximal to MLF1 (3q25) on chromosome 3.
No further probes could be tested due to lack of patient material.
Patient 7: FISH analysis indicated that the der(5) chromosome resulted from t(3;5) as evidenced with whole-chromosome painting probes. FISH analysis showed loss of signals of the probes corresponding to EGFR1, CSFR1, NPM1, RANBP17 (BAC RP11-45L16), and FLT4 (BAC RP-586L9) with normal positions on 5q31, 5q32, and 5q35, respectively, while the probes for MLF1 and BCL6 hybridized to the der(5). These results show that the chromosome 5 breakpoint was proximal to 5q31 and the chromosome 3 breakpoint proximal to 3q25. It is to note that FISH showed an additional copy of an apparently chromosome 3 (with MLF1 probe signal) in some metaphases.
Patient 8: FISH analysis with the whole chromosome painting probes for chromosomes 3 and 5 showed that der(3) received material from chromosome 5 but, that the der(5) did not received material from chromosome 3, indicating that the translocation apparently was nonreciprocal and that the chromosome 3 breakpoint was close to the distal part of the long arms as shown by the presence of probe (RP11-1152O7) covering the 5 0 part of the LPP gene on 3q28 on der(3). No signal was seen with the PAC probe GS 240G13, which detects Table 1 Chromosome studies in eight patients with t(3; der (5) MLF1 der (5) der (5) der (5) der (3) EVI1 der (3) MDS1 der (3) BCL6 der (5) der (5) The hybridization signals on unrearranged chromosomes 3 and 5 were at their normal chromosomal localization.
sequences at the subtelomeric part of 5q, indicating that the distal part of the translocated 5q segment was deleted. As expected, MLF1 remained on the der(3), and whereas NPM1 was translocated onto the der(3). The pattern of hybridization showed that NPM1 and MLF1 were not fused on the der(5).
Discussion
Four of the eight t(3;5) translocations collected in the present study were the common translocation with NPM1/MLF1 fusion was identified by FISH in three patients and RT-PCR in one. As in the cases reported in the literature, the location of the breakpoints defined with banding techniques was not always in accordance with the known chromosomal localization of the NPM1 and MLF1 loci. It could mean that the precise localization of the breakpoints remains difficult to determine with banding techniques alone, even by well-trained cytogeneticists. Alternatively, subtle rearrangements such as small deletions, insertions or, inversions, may be associated with the nonrandom t(3;5)(q24;q35) leading to distinct chromosomal breakpoints while at the molecular level the same gene rearrangement is produced.
The diversity and inaccuracy of the breakpoint assignment by chromosome banding has also been reported for 5q deletions in MDS and AML. 8 The complexity of rearrangements of chromosome 5 has previously been reported in 5q interstitial deletion 9 and the interstitial loss of 5q sequences shown noncontiguous in MDS. 10 Of further notice was the diversity of the hematopoietic disorders associated with t(3;5)(q24;q35) in this study which in keeping with the data in the literature. Patients may present with de novo AML of various FAB subtypes including M6 but except M3, diverse forms of MDS transformed in AML or not, therapyrelated AML and MDS. The respective role of NPM1, also known to be involved in t(5;17)(q35;q21) translocation of a variant form of AML-M3 with NPM/RARA fusion and in t(2;5)(p23;q35) of anaplastic large cell lymphoma with ALK/ NPM1 fusion, and of MLF1 almost entirely conserved in the fusion remains to be more deeply analyzed. An elevated expression of MLF1 has been found correlated with malignant progression from myelodysplastic syndrome as well as in some AMLs while MLF1 transcripts were mainly expressed in normal CD34 þ cells. 11 As shown from this study, NPM1/MLF1 gene fusion is not present in every t(3;5)-positive AML and MDS, as also observed by others with FISH methods. 12 Loss of genes resulted from the translocations with large deletions, as in other 5q rearrangements. Interestingly, using a NPM1 BAC probe, loss of one copy of the gene was detected in three patients with complex karyotypes. Outside its role in embryonic development, the nucleophosmin coded by the NPM1 gene has multiple functions such as a role in centrosome duplication, cell cycle, ribosome biogenenesis, regulation of TP53 and ARF activity, and response to stress stimuli. Moreover, Npm1 hemizygosity was associated with a hematological disorder in mice with some features of human MDS. 13 From these experimental data, one can infer that haploinsufficiency for NPM1 plays a role in some AML and MDS cases. Mutations of the NPM1 exon 12 gene with ectopic cytoplasmic cell localization of the nucleophosmin protein have recently been reported to occur in patients with AML and normal karyotype. [14] [15] [16] The so-called NPMc þ AMLs with NMP1 mutation show both peculiar characteristics and gene expression profile as compared with other AMLs. The NPMc þ AMLs apparently show features different from those reported in t(3;5)-positive AMLs as well as the rare cases of hematopoietic disorders with loss of one copy of NPM1. Since probes are available for FISH studies, it appears that search for NPM1 loss should be performed in AML and MDS.
